FcγR-driven chimeric receptor T cells in cancer therapy: a novel frontier in antibody-guided immunotherapy
Abstract This review article looks at a novel and flexible framework in adaptive cell treatment that enhances tumor targeting using Fc gamma receptor (FcγR)-based chimeric receptors. Though chimeric antigen receptor (CAR) T cell therapies have shown notable effectiveness in hematologic malignancies,...
Furkejuvvon:
| Váldodahkkit: | , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
BMC
2026-04-01
|
| Ráidu: | Cancer Cell International |
| Fáttát: | |
| Liŋkkat: | https://doi.org/10.1186/s12935-026-04258-7 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|